Cancer funding and Brexit

Brexit and funding for UK R&D.

THIS time last year, the UK’s electorate was gearing up to vote in a referendum to decide on the country’s future in the European Union. This week, the electorate is gearing up to vote again, this time to decide on the government it wants to lead Brexit negotiations. Among those who will be following those negotiations closely will be members of the UK’s research, development and innovation sec...

Brexit and health services.

Brexit and Translational Research

In a historic referendum on June 23, 2016, the UK voted to leave the European Union (EU) after more than four decades of membership. For the time being, the UK is still a member of the EU until the UK government triggers Article 50 of the Lisbon Treaty–which probably won't happen before the end of 2016. A minimum of 2 years of negotiations will follow before theUK ceases to be an EUmember. This...

Bubbles, Blind-Spots and Brexit

In this paper we develop a well-established financial model to investigate whether bubbles were present in opinion polls and betting markets prior to the UK’s vote on EU membership on 23 June 2016. The importance of our contribution is threefold. Firstly, our continuous-time model allows for irregularly spaced time series—a common feature of polling data. Secondly, we build on qualitative compa...

Cancer research funding in Asia.

In inner Mongolia, 4500 people die of cancer, mostly of the liver, per year. But most people in the country bordering China and Russia are dying of cardiovascular disease or infectious diseases and do not reach the age at which cancer becomes common. But in its rapidly developing neighbour, China, cancer is now a leading cause of premature death, killing 1.9 million people, most of them under 7...